BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2021
View Archived Issues
Surface Ophthalmics initiates phase II trial of SURF-200 for acute dry eye
Read More
In vivo data on IHL-675A supports expansion of indications to include COPD and asthma
Read More
Thrombin trivalent inhibitors inspired by native peptidic inhibitors from hematophagous arthropods
Read More
CD22 is a potential target for CAR T-cell therapy in LBCL after failure of autologous CAR19 therapy
Read More
FDA places clinical hold on phase IIa study of SPR-720
Read More
Ono Pharmaceutical divulges KDM5A inhibitors
Read More
Kymera Therapeutics patents CRBN inhibitors
Read More
Pfizer presents new TLR agonists
Read More
Scenic Immunology synthesizes new QC and/or QPCTL inhibitors
Read More
Good T Cells patents molecules for treating immune checkpoint inhibitor-resistant cancer
Read More
Phase III KESTREL study of Imfinzi in HNSCC does not meet its primary or secondary endpoints
Read More
SerpinPC found useful in patients with severe hemophilia
Read More
FDA approves phase I/IIa study of HDP-101 in multiple myeloma
Read More
Single-cell resolution reveals cell type, targets, for neuroblastoma
Read More
Updated patient eligibility and first-in-human data for BAY-2599023
Read More
Korean MFDS grants conditional marketing authorization for Regkirona for COVID-19
Read More
Bevacizumab shows potential benefit in COVID-19 patients
Read More
FDA grants accelerated approvals of Ukoniq for marginal zone lymphoma and follicular lymphoma
Read More
Phase I/II results for TAK-754 gene therapy in severe hemophilia A
Read More
Alphamab initiates phase I/II study of KN-046 with donafenib in HCC
Read More
Safety, immune responses reported for SARS-CoV-2 vaccine BBV-152 in clinical trial
Read More
PCOS passed on in the epigenes
Read More
Preclinical data presented for GD2-B7H3 CART in metastatic neuroblastoma
Read More
FDA approves Breyanzi for relapsed or refractory large B-cell lymphoma
Read More
Phase I trial of IDE-397 for solid tumors with MTAP deletion cleared to begin in U.S.
Read More
FDA clears IND for phase I/II study of PBKR-03 for Krabbe disease
Read More
Sinovac reports phase III data on CoronaVac
Read More
